OCBCO
NBIX icon

Oversea-Chinese Banking Corp (OCBC)’s Neurocrine Biosciences NBIX Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,676
Closed -$238K – 361
2025
Q4 		$238K Hold
1,676
– – 0.01% 311
2025
Q3 		$235K Buy
+1,676
New +$227K 0.01% 318

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s NBIX Position: Q1 2026 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Neurocrine Biosciences (NBIX) in Q1 2026, closing a stake of 1,676 shares — an estimated $238K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in NBIX in Q3 2025 and held it in 2 quarters. The position peaked at $238K in Q4 2025. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining Neurocrine Biosciences position as of Q1 2026 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 1,676 Neurocrine Biosciences shares in Q1 2026, an estimated $238K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Neurocrine Biosciences in Q3 2025 and held it in 2 quarters.
  • Oversea-Chinese Banking Corp (OCBC)'s Neurocrine Biosciences position peaked at $238K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2026, filed 28 Apr 2026.